New study: Daily cholesterol pill lowers LDL levels by up to 60 percent

Date:

Share this article:

Del denne artikel:

There’s something strangely familiar about those routine health checkups where you promise yourself you’ll “take cholesterol more seriously this time.”

Most of us know the feeling of seeing numbers creep upward, even when we’re doing our best to eat better or move more.

And for many, the idea of adding yet another injection or complicated treatment can feel overwhelming — especially if high cholesterol runs in the family.

A simpler approach for people who struggle to reach healthy levels

Across the world, researchers have been working on treatments that fit more naturally into everyday routines.

Also read: Study suggests humans can detect objects before touching them

One of the most promising developments comes from a large international study of an experimental pill called Enlicitide — a tablet designed for people whose cholesterol stays high despite existing medication.

The research included adults diagnosed with heterozygous familial hypercholesterolemia, a genetic condition that pushes LDL (“bad”) cholesterol to dangerous levels from an early age.

Participants were already on lipid-lowering therapies, but many still couldn’t reach safe targets.

The numbers that caught researchers’ attention

The group receiving Enlicitide once daily saw steep reductions in harmful fats over the course of the year. According to the study published in JAMA, the pill led to:

  • About 58 percent lower LDL after 24 weeks, stabilizing near 55 percent after a year
  • A 52 percent reduction in non-HDL cholesterol
  • A 48 percent drop in apolipoprotein B
  • Nearly 25 percent lower lipoprotein(a)

These are levels typically achieved only with injectable PCSK9 blockers — making a daily pill an attractive alternative for many patients.

Also read: New data shows Long COVID rarely follows a single pattern

What scientists still need to understand

The trial did not yet examine whether the pill reduces heart attacks, strokes or long-term mortality, and researchers emphasize that larger outcome studies are underway.

The medication was tested only in people with a specific genetic condition, so its effect in those with common high cholesterol is still unknown.

For now, the findings point to a future where managing inherited cholesterol disorders may be easier — and far more accessible — than before.

The article is based on information from Fox News Digital og JAMA

Also read: New study: Plant-based diet is most effective for weight loss

Also read: Christmas songs that could make falling asleep easier

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Eating this much fiber every day may cut your obesity risk by more than a quarter

A study of nearly 40,000 US adults points to a clear fiber threshold worth aiming for.

5 breathing techniques that may lower your blood pressure and ease anxiety

Your breath is one of the few nervous-system controls you can move on purpose.

How eating too much sugar affects your liver and raises fatty liver risk

Fructose goes straight to your liver, and too much of it can quietly build up as fat.

Can the sweetener sucralose damage your DNA? Here is what scientists have found

A sweetener has been examined in several different studies and has raised concerns, but more recent research provides a more nuanced picture.

Eating this much fiber every day may cut your obesity risk by more than a quarter

A study of nearly 40,000 US adults points to a clear fiber threshold worth aiming for.

5 breathing techniques that may lower your blood pressure and ease anxiety

Your breath is one of the few nervous-system controls you can move on purpose.

How eating too much sugar affects your liver and raises fatty liver risk

Fructose goes straight to your liver, and too much of it can quietly build up as fat.